Celgene Corporation EBITDA Margin 2010-2019 | CELG
Current and historical EBITDA (Earnings Before Interest, Taxes, Depreciation and Amortization) margin for Celgene Corporation (CELG) over the last 10 years. The current EBITDA margin for Celgene Corporation as of September 30, 2019 is .
EBITDA Margin Historical Data |
Date |
TTM Revenue |
TTM EBITDA |
EBITDA Margin |
2019-09-30 |
$16.98B |
$8.52B |
50.16% |
2019-06-30 |
$16.35B |
$7.96B |
48.69% |
2019-03-31 |
$15.77B |
$7.35B |
46.61% |
2018-12-31 |
$15.28B |
$5.83B |
38.13% |
2018-09-30 |
$14.73B |
$5.19B |
35.26% |
2018-06-30 |
$14.12B |
$4.51B |
31.96% |
2018-03-31 |
$13.58B |
$4.29B |
31.61% |
2017-12-31 |
$13.00B |
$5.18B |
39.82% |
2017-09-30 |
$12.50B |
$4.93B |
39.45% |
2017-06-30 |
$12.20B |
$4.26B |
34.93% |
2017-03-31 |
$11.68B |
$3.76B |
32.16% |
2016-12-31 |
$11.23B |
$3.67B |
32.69% |
2016-09-30 |
$10.81B |
$3.63B |
33.54% |
2016-06-30 |
$10.16B |
$3.27B |
32.16% |
2016-03-31 |
$9.69B |
$2.85B |
29.39% |
2015-12-31 |
$9.26B |
$2.66B |
28.71% |
2015-09-30 |
$8.78B |
$2.48B |
28.19% |
2015-06-30 |
$8.43B |
$3.04B |
36.12% |
2015-03-31 |
$8.02B |
$3.38B |
42.18% |
2014-12-31 |
$7.67B |
$2.89B |
37.66% |
2014-09-30 |
$7.34B |
$2.47B |
33.67% |
2014-06-30 |
$7.03B |
$2.28B |
32.43% |
2014-03-31 |
$6.76B |
$2.09B |
30.88% |
2013-12-31 |
$6.49B |
$2.18B |
33.62% |
2013-09-30 |
$6.19B |
$2.17B |
35.12% |
2013-06-30 |
$5.93B |
$2.19B |
36.96% |
2013-03-31 |
$5.70B |
$2.04B |
35.84% |
2012-12-31 |
$5.51B |
$2.03B |
36.87% |
2012-09-30 |
$5.34B |
$2.12B |
39.62% |
2012-06-30 |
$5.17B |
$2.07B |
40.07% |
2012-03-31 |
$4.99B |
$1.97B |
39.56% |
2011-12-31 |
$4.84B |
$1.81B |
37.30% |
2011-09-30 |
$4.63B |
$1.63B |
35.25% |
2011-06-30 |
$4.29B |
$1.48B |
34.45% |
2011-03-31 |
$3.96B |
$1.30B |
32.83% |
2010-12-31 |
$3.63B |
$1.25B |
34.45% |
2010-09-30 |
$3.32B |
$1.24B |
37.25% |
2010-06-30 |
$3.10B |
$1.13B |
36.52% |
2010-03-31 |
$2.88B |
$1.10B |
38.11% |
2009-12-31 |
$2.69B |
$0.97B |
35.99% |